Which countries run stem-cell trials for Cerebral Palsy?
Sites appear in 16 countries, led by United States at about 28% of all country mentions (2026-08-29).
Country distribution
| Country | Studies with a site there |
|---|---|
| United States | 10 |
| Mexico | 4 |
| India | 4 |
| South Korea | 3 |
| Iran | 3 |
| China | 3 |
| Vietnam | 3 |
| United Arab Emirates | 2 |
| Greece | 2 |
| Russia | 2 |
A study with sites in several countries is counted once per country, taken from the location block of each registry record.
What the map means for Cerebral Palsy
Registered paediatric studies concentrate in centres with paediatric neurology and standardised motor assessment. In parallel, cerebral palsy is one of the most heavily marketed indications to families travelling abroad — an asymmetry worth holding in mind when a clinic cites 'hundreds of studies'.
Where recruitment is actually open
| Country | Open studies with a site there |
|---|---|
| United Arab Emirates | 1 |
| United States | 1 |
| Antigua and Barbuda | 1 |
| Greece | 1 |
What travelling for a trial actually involves
Distance changes the risk calculus. Registered studies are designed around continuity of care, so a site will normally decline participants it cannot monitor — which is exactly the safeguard a commercial clinic does not apply.
Multi-country studies, named
Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.
- NCT05018819 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP (Antigua and Barbuda, Greece)
- NCT02795052 — Neurologic Stem Cell Treatment Study (United Arab Emirates, United States)
Why trial geography is not a shortlist
The map is drawn by policy and money. Permissive or well-defined regulatory pathways attract registrations and large research budgets attract more still. None of that transfers to the private clinic advertising in the same city, which may operate under no comparable supervision.
Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.
When these studies started
Registrations by start year since 2020: 2020 (2), 2021 (1), 2022 (1), 2025 (1), 2026 (1). Activity for this condition spans 2009 to 2026, which shows whether interest is growing, flat or past its peak.
Frequently asked
Which countries run stem-cell trials for Cerebral Palsy?
Sites are registered in 16 countries; the largest is United States (~28% of country mentions, 2026-08-29).
Does a country with many trials mean better treatment there?
Volume tracks funding and law, not outcomes. The relevant question is what oversight covers the specific clinic and product you are considering.
Are trial sites and commercial clinics the same thing?
Mostly no. Some clinics imply an association with local research institutions; the registry record names the actual sponsor and site, which settles it.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.